T

Third Harmonic Bio

28 employees

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2019

Funding rounds raised

Total raised

$105M

from 7 investors over 7 rounds

T

Third Harmonic Bio raised $105M on January 16, 2022

Investors: RA Capital Management, L.P., RTW Investments, LP, Ajax Health, General Atlantic and Commodore Capital, LP

T

Third Harmonic Bio raised $50M on January 1, 2019

Investors: Atlas Venture and OrbiMed Advisors

FAQ